Our Technology

Early Detection Saves Lives

Diving into Our Technology

Our non-intrusive testing, AI-powered cancer detection and patented Cell-CT imaging work together to deliver early detection of lung cancer.

Learn more about our breakthrough technologies below.

Non-Intrusive
Testing

Using Our LuCED® Test Kit

The LuCED test, or Lung Cell Evaluation Device, does not require a blood draw, and uses a non-intrusive sputum sample that will be analyzed to determine your risk of lung cancer.

How We Collect Your Sample

3D Cell Imaging

Using Our Patented Cell-CT
Imaging Platform

Through our AI-powered technology, 3D cell images are able to be pulled and analyzed to determine lung cancer detection. This process is followed up with CellGazer which gives a review of the cell analysis.

How We Test Your Sample

AI-Powered
Cancer Early Detection

Analyzing Results with CellGazer Technology

Through our AI-powered technology, 3D cell images are computed and analyzed to detect abnormal cells in lung cancer. This process is followed up with CellGazer which gives a review of the cell analysis.

How We Analyze Your Sample

VisionGate Blog

Learn more about the latest published studies VisionGate has submitted to the scientific community and the ongoing research and development on lung cancer and the importance of early detection.

View All

Latest
News

Research &
Development

Published
Studies